Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerular Nephritis”

861 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 861 results

Very early researchStudy completedNCT03763643
What this trial is testing

PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant

Who this might be right for
Focal Segmental Glomerulosclerosis
University of Minnesota 21
Post-approval studies (Phase 4)Not Yet RecruitingNCT06528015
What this trial is testing

Efficacy and Safety of Probiotics Combined With Enteric-coated Budesonide Capsules in Patients With Primary IgA Nephropathy

Who this might be right for
Glomerulonephritis, IGAProbioticsBudesonide
Gang Xu 206
Testing effectiveness (Phase 2)Ended earlyNCT03943147
What this trial is testing

An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Bristol-Myers Squibb 16
Very early researchWithdrawnNCT06926985
What this trial is testing

An Exploratory Clinical Study of Anti-CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in the Treatment of IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)
Jieyang People's Hospital
Not applicableStudy completedNCT03687138
What this trial is testing

Searching for Diagnostic/Prognostic Biomarkers in SLE With Renal Involvement by Proteomic Techniques

Who this might be right for
Lupus NephritisLupus Erythematosus, Systemic
Natalia A. Rivera García 124
Very early researchNot Yet RecruitingNCT06485648
What this trial is testing

Mesenchymal Stem Cell Transfusion for the Treatment of Refractory Lupus Nephritis

Who this might be right for
Lupus Nephritis
Chinese PLA General Hospital 96
Testing effectiveness (Phase 2)Study completedNCT04014335
What this trial is testing

Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Ionis Pharmaceuticals, Inc. 23
Not applicableUnknownNCT00378443
What this trial is testing

ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT

Who this might be right for
Glomerulonephritis, IGA
Peking University
Testing effectiveness (Phase 2)Study completedNCT00004990
What this trial is testing

Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis

Who this might be right for
GlomerulonephritisNephrotic Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 20
Large-scale testing (Phase 3)Ended earlyNCT00318474
What this trial is testing

Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy

Who this might be right for
IgA Nephropathy
St. Joseph's Hospital and Medical Center, Phoenix 184
Testing effectiveness (Phase 2)Study completedNCT00040508
What this trial is testing

Sirolimus for Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Glomerulosclerosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 30
Testing effectiveness (Phase 2)Study completedNCT00001789
What this trial is testing

BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis

Who this might be right for
Glomerulonephritis, MembranoproliferativeLupus Nephritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 20
Not applicableApproved For MarketingNCT04729062
What this trial is testing

C3G/Primary IC-MPGN EAP

Who this might be right for
C3GIC-MPGNC3 Glomerulopathy+9 more
Apellis Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Active Not RecruitingNCT06291376
What this trial is testing

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Immunoglobulin A NephropathyIgAN
Alexion Pharmaceuticals, Inc. 579
Large-scale testing (Phase 3)Not Yet RecruitingNCT07807995
What this trial is testing

Open-Label Study of Long-term Treatment With Povetacicept in Adults With Immunoglobulin A Nephropathy

Who this might be right for
Immunoglobulin A Nephropathy
Vertex Pharmaceuticals Incorporated 605
Testing effectiveness (Phase 2)Ended earlyNCT03598036
What this trial is testing

Dose-Exploration Evaluating the Efficacy and Safety of Voclosporin in Subjects With Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental Glomerulosclerosis
Aurinia Pharmaceuticals Inc. 5
Not applicableLooking for participantsNCT06927219
What this trial is testing

Research Accelerated by You Lupus Registry

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Cutaneous Lupus Erythematosus (CLE)
Lupus Foundation of America 10,000
Large-scale testing (Phase 3)WithdrawnNCT01288664
What this trial is testing

Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Phase Treatment in Lupus Nephritis

Who this might be right for
Lupus Nephritis
Sun Yat-sen University
Testing effectiveness (Phase 2)Study completedNCT03393013
What this trial is testing

KZR-616 in Patients With SLE With and Without Lupus Nephritis

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus
Kezar Life Sciences, Inc. 69
Large-scale testing (Phase 3)Looking for participantsNCT05755386
What this trial is testing

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

Who this might be right for
IC-MPGN
Novartis Pharmaceuticals 106
Next Page